Calderas, C., Taramasso, M., Levy, J., Rojas, J., Piamo, L., Rodriguez, H., De Santolo, G., Reinaga, M., Ribichini, F., & Bilgi, K. V. (2025). Initial experience with the Crea Aortic Valve System – a first-in-human study. AsiaIntervention, 11(1), 52–59.

https://doi.org/10.4244/AIJ-D-24-00023

Abstract:

Background: Transcatheter aortic valve implantation (TAVI) is a minimally invasive option for severe aortic stenosis (AS). The Crea Aortic Valve (CAV) is a new self-expanding transcatheter aortic valve implant that has been successfully tested in preclinical studies.

Aims: We aimed to assess the technical success, device performance, and early safety of the CAV System in a first-in-human study for the device in patients with severe AS.

Methods: We prospectively evaluated the CAV using the Valve Academic Research Consortium (VARC)-3 criteria in three high-risk patients with severe AS. A computed tomography angiography and transthoracic echocardiographic (TTE) assessment were carried out, which was followed by TAVI according to standard protocol. TTE was performed before and after the procedure, before discharge, and at the 1- and 6-month clinical follow-ups to monitor the aortic valve area, the maximum velocity (Vmax), the mean (MG) and peak pressure gradients, and paravalvular leak (PVL).

Publications info:

  • 4
  • 1
  • April 2025
Chat on WhatsApp Book A Session